The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEVG.L Share News (EVG)

  • There is currently no data for EVG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Cambria drives on amid virus; Argo crypto mining up

Wed, 03rd Mar 2021 20:16

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Cambria Automobiles PLC - franchised motor retailer - Says continued to be hurt by UK Covid-19 restrictions in five months to January 31. Welcomes reopening of car showrooms penned for April but warns will miss out on busiest month of trading in March. Says overall trading performance during five-month period improves amid Covid-19-related cost reductions. "Whilst the group's trading performance in the first five months of the financial year is pleasing, given the potential impact that the lockdown restrictions could have had in the period, the results have benefitted from the government support stimulus," Cambria adds.

----------

Argo Blockchain PLC - cryptocurrency miner - Mines 129 bitcoin or bitcoin equivalent in February, compared to 93 in January. Mining revenue rises to GBP4.3 million in February, from GBP2.5 million in January. "At the end of February, the company held 599 BTC," Argo adds.

----------

Gore Street Energy Storage Fund PLC - London-based investor in utility-scale energy storage projects - participates in National Grid PLC's dynamic containment service, notching firm another revenue stream. Dynamic containment service ensures grid's frequency stays within statutory range of +/-0.5 hertz. "We are delighted to announce our participation in the new dynamic containment service developed by the National Grid, which could create a material uplift in the company's revenue across the majority of our operational portfolio if the pricing trends continue," says Alex O'Cinneide, chief executive officer of Gore Street's investment manager.

----------

Kropz PLC - South Africa-focused plant nutrient feed minerals developer - Makes quarterly draw down of loan facility with shareholder ARC Fund. "The fifth draw down under the original equity facility is for USD7 million," Kropz says. Adds that drawdown will be settled through issue of 89.2 million shares at 6.75 pence each. In addition, Kropz draws down USD2 million from a new equity facility.

----------

Wishbone Gold PLC - precious metals trading and exploration company with assets in Australia - Signs deal to acquire Cottesloe silver project in Australia, more than doubling exposure in Patersons province. To issue Alta Zinc Ltd 600,000 new shares at 14 pence each, GBP84,000 in total. "With silver becoming increasingly in demand with the climate change agenda initiatives, the silver potential is exceptional here at Cottesloe," Chair Richard Poulden says.

----------

Pure Gold Mining Inc - Canadian gold miner - Says gold pours and shipments at PureGold Mine in Red Lake, Ontario ramping up "regularly". "With the steady progress of mining and milling performance throughout the ramp-up period toward the design production rate of 800 tonnes per day, the company currently anticipates declaring commercial production at the PureGold Mine in Q2 2021," company adds.

----------

Inspired Energy PLC - Lancashire-based energy procurement consultant - Completes buys of BWS Holdco Ltd, its trading unit Businesswise Solutions Ltd and General Energy Management Ltd. Buys funded from Inspired's GBP31.3 million July fundraise. "We are delighted to conclude the acquisition of Businesswise and GEM, which are highly complementary additions to the group. Both acquisitions increase our market share for energy assurance services, broaden our customer base and significantly increase our units of opportunity," CEO Mark Dickinson adds.

----------

W Resources PLC - tungsten, tin and gold mining company with assets in Spain and Portugal - Says plant improvement work at La Parrilla mine in Spain has been completed. Notes "improved efficiency and increased production of tin and tungsten concentrate" at mine.

----------

Reabold Resources PLC- London-based oil and gas project investor - Begins sale of GBP500,000 of convertible loan notes in Corallian Energy Ltd. "As previously announced, the CLN will help to fund the submission of a draft Field Development Plan for the Victory gas field, which Corallian plans to submit prior to the end of 2021," Reabold says.

----------

Uru Metals Ltd - exploration and development firm - Proposed disposal of its 80% stake in Zebediela nickel project in South Africa to Blue Rhino Capital Corp. Blue Rhino will complete share consolidation and non-brokered private placement to raise CAD2.3 million, about GBP1.3 million. Notes disposal requires shareholder approval.

----------

Solid State PLC - Worcestershire-based computing products manufacturer - Buys Willow Technologies Ltd, a maker of electro-mechanical products, for an initial GBP10.0 million. Solid State notes acquisition has maximum earnout of GBP3.5 million.

----------

SourceBio International PLC - Nottingham-based laboratory services provider - Says laboratory operations in San Diego, California to expand to include Covid-19 PCR testing services. "This further investment in our San Diego facility increases our overall capacity to increase Covid-19 qPCR testing services by up to an additional 5,000 samples per day and means we can address the clear market demand for Covid-19 testing in the US," Executive Chair Jay LeCoque says.

----------

Aberdeen Asian Income Fund Ltd - closed-end fund concentrated on Asian equities - Renews both its three-year GBP10 million loan facility and GBP40 million one-year facility with Bank of Nova Scotia, London Branch for a further three years. "Under the terms of the revolving credit facility, the company also has the option to increase the level of the commitment from GBP40 million to GBP60 million at any time," company adds.

----------

Evgen Pharma PLC - Liverpool-based clinical stage drug development company - Completes open offer, taking total fundraising to GBP11 million. In February, Evgen said it planned to raise funds to support completion of formulation and scale up manufacturing of breast cancer product SFX-01.

----------

Victoria PLC - Worcestershire-headquartered flooring firm - Says EUR127.9 million of outstanding senior secured notes due 2024 validly tendered and accepted for repurchase for EUR133.7 million. Says EUR348.1 million in notes remain outstanding.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
25 Apr 2024 20:57

TRADING UPDATES: Norcros sells Johnson Tiles UK; Trifast trading well

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
4 Apr 2024 17:24

TRADING UPDATES: Northcoders launches bootcamp; Schroder invests

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
19 Mar 2024 19:47

EARNINGS AND TRADING: Ten Lifestyle sees profit up but sales flat

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
27 Feb 2024 15:59

Evgen Pharma finds evidence of SFX-01 activity in colon cancer models

(Alliance News) - Evgen Pharma PLC on Tuesday said it found further evidence of SFX-01 activity in models of colon cancer.

Read more
19 Feb 2024 11:45

Evgen Pharma shares up on studies into SFX-01 product progressing well

(Alliance News) - Evgen Pharma PLC on Monday said the studies into its SFX-01 product were progressing positively regarding its activity in Glioblastoma cells.

Read more
9 Feb 2024 18:53

TRADING UPDATES: Apax opts against lifting offer; DCI enters loan deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
9 Feb 2024 17:02

LONDON MARKET CLOSE: FTSE 100 falls at end of tepid week

(Alliance News) - Stock prices in London closed lower on Friday, with the FTSE 100's losing streak extending to three days, as sentiment in Europe remains tetchy despite a largely stellar start to the day in New York.

Read more
16 Jan 2024 18:59

IN BRIEF: Evgen partner raises USD17.4 million to support pipeline

Evgen Pharma PLC - clinical stage drug development company developing sulforaphane-based medicines - Notes that its partner in autism spectrum disorder and other neurodevelopmental disorders Stalicla SA has announced that it has raised USD17.4 million, inclusive of a credit facility. This is to to support programmes on STP1, Stalicla's first asset in ASD, and a further asset in substance use disorders together with a biosampling and patient identification study in ASD. Evgen says it continues to work with Stalicla on delivery of a milestone payment for SFX-01 (Stalicla's STP2). Evgen says both parties are engaged in analysis and interpretation of Evgen's recent Phase 1b healthy volunteer PK/PD study and the implications for a future phase 2 trial in ASD. Evgen says it will provide updates on the status of the programme in "due course" and has not anticipated any milestone payments from Stalicla in its financial forecasting.

Read more
22 Dec 2023 18:06

IN BRIEF: Evgen appoints Toni Hanninen as permanent CFO

Evgen Pharma PLC - clinical stage drug development company developing sulforaphane-based medicines - Appoints Toni Hanninen as permanent chief financial officer, adding that he will now join the board as a director. Hanninen was appointed as interim CFO in September, having previously worked at Faron Pharmaceuticals Ltd. His permanent appointment becomes effective from January 1. Evgen also confirms that non-executive director, Susan Clement-Davies, will be retiring from the board.

Read more
31 Oct 2023 14:38

TRADING UPDATES: Acuity RM wins contract; Georgia Capital ups earnings

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday, and not separately reported by Alliance News:

Read more
26 Oct 2023 11:08

Evgen upbeat on start of glioblastoma research project

(Sharecast News) - Clinical-stage drug developer Evgen Pharma announced on Thursday that it has partnered with Dr Marjolein Geurts, a neuro-oncologist at Erasmus University Medical Centre, to start a ground-breaking research initiative in glioblastoma.

Read more
19 Oct 2023 19:39

IN BRIEF: Evgen showcases importance of new enteric-coated formulation

Evgen Pharma PLC - Cheshire, England-based clinical stage drug developer - Highlights article published in respected industry publication the Medicine Maker, by its Chief Business Officer, Helen Kuhlman. The article, entitled the Sulforaphane Promise, focuses on the recent study of Evgen's new enteric-coated tablet formulation, and why enteric coatings are of particular importance for a stabilised complex such as SFX-01 that releases highly biologically active sulforaphane. The SFX-01 complex is vulnerable to breakdown in acid conditions and the enteric coat prevents acid attack in the stomach, releasing the drug in the ideal region - the small bowel. It also discusses the pharmacodynamic and pharmacokinetic data from the recent study, demonstrating the improvements of the tablet formulation over previous formulations of SFX-01.

Read more
5 Sep 2023 14:22

Evgen Pharma hires interim CFO from Faron, chair to retire this month

(Alliance News) - Evgen Pharma on Tuesday said Non-Executive Chair Barry Clare will retire at its next board meeting, and announced the hiring of interim Chief Financial Officer Toni Hanninen.

Read more
15 Aug 2023 10:01

Evgen Pharma says trial shows new SFX-01 drug formulation is safe

(Alliance News) - Evgen Pharma PLC on Tuesday said final data from a trial of its SFX-01 therapy has shown a new formulation of the drug is safe.

Read more
2 Aug 2023 10:28

IN BRIEF: Evgen Pharma shares drop on ending of license agreement

Evgen Pharma PLC - Cheshire, England-based clinical stage drug development company focused on developing sulforaphane-based medicines - Terminates the patent and know-how license agreement for its Sulforadex sulforaphane stabilisation technology with partner JuvLife Ltd. The exclusive rights will be returned in the final quarter of 2023. The already received upfront payment is non-refundable.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.